Molecular aspects of B-lymphocyte activation.

The activation of B lymphocytes from the resting stage to the proliferating stage and then to the fully differentiated antibody-secreting stage is a highly regulated and complicated process. B-cell activation can clearly proceed by a number of different routes, each promoted by different regulatory cells (macrophages, two types of helper T cells) and each dependent upon the properties of the relevant antigen molecules. In most cases the nature of the antigen may simply control the magnitude and/or duration of antigen receptor signaling. An antigen that by itself generates inefficient signaling may require additional signals from helper T cells to induce B-cell activation. In contrast, antigens derived from bacterial cell surface components, such as LPS, can directly activate B cells and macrophages. This vigorous, polyclonal responsiveness to certain bacterial components probably represents a specialized system to enhance antibody responses to bacteria, whereas helper T cell-dependent responses may be primarily useful in making antibodies against soluble proteins and viruses. Thus multiple pathways of B-cell activation probably are needed to generate adequate antibody responses against the variety of pathogenic micro-organisms encountered by vertebrates.

[1]  W. Paul,et al.  Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Rogers,et al.  Two mRNAs with different 3′ ends encode membrane-bound and secreted forms of immunoglobulin μ chain , 1980, Cell.

[3]  G. Pier,et al.  Polyclonal B cell stimulation and interleukin 1 induction by the mucoid exopolysaccharide of Pseudomonas aeruginosa associated with cystic fibrosis. , 1985, Journal of immunology.

[4]  A. Coutinho,et al.  Clonal growth and maturation to immunoglobulin secretion in vitro of every growth-inducible B lymphocyte , 1977, Cell.

[5]  C. Hawrylowicz,et al.  Activation and proliferation signals in mouse B cells. III. Intact (IGG) anti-immunoglobulin antibodies activate B cells but inhibit induction of DNA synthesis. , 1984, Immunology.

[6]  L. Bourguignon,et al.  Capping and the cytoskeleton. , 1984, International review of cytology.

[7]  E. Margoliash,et al.  Anti-immunoglobulin augments the B-cell antigen-presentation function independently of internalization of receptor-antigen complex. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Crumpton,et al.  Actin may be present on the lymphocyte surface. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Billiau BSF-2 is not just a differentiation factor , 1986, Nature.

[10]  D. Morrison,et al.  Bacterial endotoxins and host immune responses. , 1979, Advances in immunology.

[11]  C. Janeway,et al.  The specific direct interaction of helper T cells and antigen-presenting B cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[12]  L. Cantley,et al.  Lipopolysaccharide and phorbol esters induce differentiation but have opposite effects on phosphatidylinositol turnover and Ca2+ mobilization in 70Z/3 pre-B lymphocytes. , 1985, The Journal of biological chemistry.

[13]  H. Grey,et al.  Antigen presentation by normal B cells, B cell tumors, and macrophages: functional and biochemical comparison. , 1982, Journal of immunology.

[14]  G. Nemerow,et al.  Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2) , 1985, Journal of virology.

[15]  R. Moor,et al.  Micro-injection of inositol 1,3,4,5-tetrakisphosphate activates sea urchin eggs by a mechanism dependent on external Ca2+. , 1986, The Biochemical journal.

[16]  P. Marrack,et al.  Interleukin-induced increase in Ia expression by normal mouse B cells , 1984, The Journal of experimental medicine.

[17]  L. Bourguignon,et al.  A lymphoma plasma membrane-associated protein with ankyrin-like properties , 1986, The Journal of cell biology.

[18]  P. Åman,et al.  Soluble factor requirements for the autostimulatory growth of B lymphoblasts immortalized by Epstein-Barr virus , 1984, The Journal of experimental medicine.

[19]  J. Levine,et al.  Redistribution of fodrin (a component of the cortical cytoplasm) accompanying capping of cell surface molecules. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Kuehl,et al.  Biosynthesis and regulation of immunoglobulins. , 1983, Annual review of immunology.

[21]  G. Pier,et al.  Induction of human interleukin-1 by toxic-shock-syndrome toxin-1. , 1985, The Journal of infectious diseases.

[22]  B. Pernis,et al.  Internalized membrane immunoglobulin meets intracytoplasmic DR antigen in human B lymphoblastoid cells , 1983, European journal of immunology.

[23]  R. Booth,et al.  Constitutive production by the WEHI-3 cell line of B cell growth and differentiation factor that co-purifies with interleukin 1. , 1983, Journal of immunology.

[24]  T. Hirano,et al.  Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Marrack,et al.  Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays , 1983, The Journal of experimental medicine.

[26]  W. Paul,et al.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2 , 1982, The Journal of experimental medicine.

[27]  R. Coffman,et al.  A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. , 1986, Journal of immunology.

[28]  E. C. Snow,et al.  Activation of antigen-enriched B cells. II. Role of linked recognition in B cell proliferation to thymus-dependent antigens. , 1983, Journal of immunology.

[29]  H. von Boehmer,et al.  Dissociation of two signals required for activation of resting B cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[30]  F. Melchers,et al.  Requirement for macrophages or for macrophage‐ or T cell‐derived factors in the mitogenic stimulation of murine B lymphocytes by lipopolysaccharides , 1983, European journal of immunology.

[31]  R. Palmiter,et al.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.

[32]  F. Melchers,et al.  The action of human C3 in soluble or cross‐linked form with resting and activated murine B lymphocytes , 1985, European journal of immunology.

[33]  G. Gabbiani,et al.  Actin and tubulin co-cap with surface immunoglobulins in mouse B lymphocytes , 1977, Nature.

[34]  J. Uhr,et al.  A B cell growth factor-like activity is secreted by cloned, neoplastic B cells. , 1984, Journal of immunology.

[35]  F. Finkelman,et al.  Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin. , 1981, Journal of immunology.

[36]  M. Raff,et al.  Redistribution and pinocytosis of lymphocyte surface immunoglobulin molecules induced by anti-immunoglobulin antibody. , 1971, Nature: New biology.

[37]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[38]  H. Grey,et al.  Capacity of B cells to function as stimulators of a primary mixed leukocyte reaction. , 1986, Journal of immunology.

[39]  W. Paul,et al.  Anti-immunoglobulin and phorbol ester induce phosphorylation of proteins associated with the plasma membrane and cytoskeleton in murine B lymphocytes. , 1986, The Journal of biological chemistry.

[40]  J. Monroe,et al.  Molecular events in B cell activation. I. Signals required to stimulate G0 to G1 transition of resting B lymphocytes. , 1985, Journal of immunology.

[41]  A. Fauci,et al.  Production of B cell growth factor by normal human B cells. , 1986, Journal of immunology.

[42]  M. Gefter,et al.  Interaction of peptide antigens and class II major histocompatibility complex antigens , 1986, Nature.

[43]  E. Unanue,et al.  Redistribution of myosin accompanying capping of surface Ig , 1977, The Journal of experimental medicine.

[44]  F. Burnet The clonal selection theory of acquired immunity , 1959 .

[45]  E. Unanue,et al.  Binding of immunogenic peptides to Ia histocompatibility molecules , 1985, Nature.

[46]  P. Leder,et al.  Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor , 1983, Cell.

[47]  M. Karnovsky,et al.  Participation of calmodulin in immunoglobulin capping , 1982, The Journal of cell biology.

[48]  J. H. Li,et al.  Phorbol myristate acetate inhibits anti-IgM-mediated signaling in resting B cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. Emerson,et al.  Linkage between surface immunoglobulin and cytoskeleton of B lymphocytes may involve Gc protein , 1983, Nature.

[50]  Y. S. Choi,et al.  Relation between actin-associated proteins and membrane immunoglobulin in B-cells. , 1982, Molecular immunology.

[51]  H. Grey,et al.  Isolation and characterization of antigen-la complexes involved in T cell recognition , 1986, Cell.

[52]  Y. Nishizuka The role of protein kinase C in cell surface signal transduction and tumour promotion , 1984, Nature.

[53]  G. Klaus,et al.  Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors , 1985, The Journal of experimental medicine.

[54]  C. Sahasrabuddhe,et al.  Biochemical separation of a human B cell mitogenic factor. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[55]  H. Tony,et al.  Major histocompatibility complex-restricted, polyclonal B cell responses resulting from helper T cell recognition of antiimmunoglobulin presented by small B lymphocytes , 1985, The Journal of experimental medicine.

[56]  T. Kishimoto,et al.  B cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes. , 1986, Journal of immunology.

[57]  M. Raff,et al.  The carrier effect in the secondary response to hapten‐protein conjugates. II. Cellular cooperation , 1971, European journal of immunology.

[58]  E. Unanue,et al.  Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction. , 1976, Advances in immunology.

[59]  A. Fauci,et al.  Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factor , 1985, The Journal of experimental medicine.

[60]  C. Raetz,et al.  The activation of protein kinase C by biologically active lipid moieties of lipopolysaccharide. , 1984, The Journal of biological chemistry.

[61]  A. Fauci,et al.  Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. , 1986, Science.

[62]  A. DeFranco,et al.  Cross-linking membrane IgM induces production of inositol trisphosphate and inositol tetrakisphosphate in WEHI-231 B lymphoma cells. , 1987, Journal of immunology.

[63]  E. Unanue,et al.  Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[64]  P. Baker,et al.  GENETIC CONTROL OF THE ANTIBODY RESPONSE TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE IN MICE , 1972, The Journal of experimental medicine.

[65]  L. Stryer,et al.  G proteins: a family of signal transducers. , 1986, Annual review of cell biology.

[66]  D. Fearon,et al.  Complement ligand-receptor interactions that mediate biological responses. , 1983, Annual review of immunology.

[67]  M. Howard,et al.  Induction of antigen-specific proliferation in affinity-purified small B lymphocytes: requirement for BSF-1 by type 2 but not type 1 thymus-independent antigens. , 1986, Journal of immunology.

[68]  C. Janeway,et al.  Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells , 1983, The Journal of experimental medicine.

[69]  G. Klaus,et al.  Interleukin 4 (B-cell growth factor II/eosinophil differentiation factor) is a mitogen and differentiation factor for preactivated murine B lymphocytes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[70]  J. Fothergill,et al.  B Lymphocyte: Activation by Insoluble Anti-Immunoglobulin: Induction of Immunoglobulin Secretion by a T Cell-Dependent Soluble Factor , 1979, The Journal of Immunology.

[71]  J. Cambier,et al.  Translocation of protein kinase C during membrane immunoglobulin-mediated transmembrane signaling in B lymphocytes. , 1986, Journal of immunology.

[72]  I. Scher,et al.  The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. , 1982, Advances in immunology.

[73]  G. Möller Effects of anti-immunoglobulin sera on B lymphocyte functions. , 1978, Scandinavian journal of immunology.

[74]  J. Stavnezer,et al.  Immunoglobulin heavy chain switching in cultured I.29 murine B lymphoma cells: commitment to an IgA or IgE switch. , 1984, Current topics in microbiology and immunology.

[75]  Antonio Lanzavecchia,et al.  Antigen-specific interaction between T and B cells , 1985, Nature.

[76]  F. Melchers,et al.  Factors controlling the B-cell cycle. , 1986, Annual review of immunology.

[77]  P. Marrack,et al.  Role of γ-interferon in antibody-producing responses , 1984, Nature.

[78]  F. Finkelman,et al.  Interferon-gamma suppresses B cell stimulation factor (BSF-1) induction of class II MHC determinants on B cells. , 1986, Journal of immunology.

[79]  J. Kappler,et al.  Is There Evidence for a Non-Antigen Specific Diffusable Chemical Mediator from the Thymus-Derived Cell in the Initiation of the Immune Response? , 1971 .

[80]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[81]  M. Gurney,et al.  Neuroleukin: a lymphokine product of lectin-stimulated T cells. , 1986, Science.

[82]  B. Vogelstein,et al.  Specific cellular stimulation in the primary immune response: experimental test of a quantized model. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[83]  C. Janeway,et al.  Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted , 1981, Nature.

[84]  J. Condeelis,et al.  Calmodulin localization during capping and receptor-mediated endocytosis , 1981, Nature.

[85]  D. Parker,et al.  Fc-dependent inhibition of mouse B cell activation by whole anti-mu antibodies. , 1983, Journal of immunology.

[86]  J. Gordon,et al.  Immortalized B lymphocytes produce B-cell growth factor , 1984, Nature.

[87]  P. Arnaud,et al.  Gc (vitamin D binding protein) binds to cytoplasm of all human lymphocytes and is expressed on B-cell membranes. , 1984, Clinical immunology and immunopathology.

[88]  T. Kishimoto,et al.  Regulation of antibody response in vitro. IV. Heavy chain antigenic determinants on hapten-specific memory cells. , 1972, Journal of immunology.

[89]  J. Cambier,et al.  B cell activation. VIII. Membrane immunoglobulins transduce signals via activation of phosphatidylinositol hydrolysis. , 1984, Journal of immunology.

[90]  J. Exton,et al.  Perturbation of the human T-cell antigen receptor-T3 complex leads to the production of inositol tetrakisphosphate: evidence for conversion from inositol trisphosphate. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[91]  A. Kraft,et al.  Decrease in cytosolic calcium/phospholipid-dependent protein kinase activity following phorbol ester treatment of EL4 thymoma cells. , 1982, The Journal of biological chemistry.

[92]  J. Kettman,et al.  Activation of murine B lymphocytes. III. Stimulation of B lymphocyte clonal growth with lipopolysaccharide and dextran sulfate. , 1981, Journal of immunology.

[93]  T. Hamilton,et al.  The cell biology of macrophage activation. , 1984, Annual review of immunology.

[94]  E. Lapetina,et al.  Pertussis toxin inhibits chemotactic peptide-stimulated generation of inositol phosphates and lysosomal enzyme secretion in human leukemic (HL-60) cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[95]  E. Lazarides,et al.  Involvement of spectrin in cell-surface receptor capping in lymphocytes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[96]  T. Schulz,et al.  Growth control of activated, synchronized murine B cells by the C3d fragment of human complement , 1985, Nature.

[97]  A. W. Harris,et al.  The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice , 1986, Cell.

[98]  B. Beutler,et al.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells , 1985, The Journal of experimental medicine.

[99]  J. Condeelis,et al.  Role of coated vesicles, microfilaments, and calmodulin in receptor- mediated endocytosis by cultured B lymphoblastoid cells , 1980, The Journal of cell biology.

[100]  A. Fauci,et al.  Development of a human T-T cell hybridoma secreting B cell growth factor , 1983, Journal of Experimental Medicine.

[101]  E. Wecker,et al.  Replacement of T-cell function by a T-cell product. , 1972, Nature: New biology.

[102]  J. Uhr,et al.  Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.